5-Amino-1MQ (5mg)

5-Amino powder is a refined, research-grade compound designed for use in laboratory settings. It is a potent inhibitor of the enzyme NNMT, which plays a critical role in energy metabolism and fat storage within the body. By inhibiting NNMT, 5-Amino-1MQ powder can modulate the methylation potential of cells and influence the metabolic pathways associated with obesity and type 2 diabetes.
5-Amino 1MQ and NNMT Inhibition
5-Amino peptide inhibits NNMT, an enzyme predominantly active in fat tissue and linked to obesity and type 2 diabetes. By blocking NNMT, 5-Amino 1MQ disrupts the enzyme’s role in metabolism and energy homeostasis, presenting a unique opportunity to study these processes in detail.
Weight Loss and Obesity Management
Studies indicate that NNMT inhibition by compounds such as 5-Amino-1MQ can result in reduced fat mass and improved insulin resistance. This is particularly significant for obesity research, as NNMT levels are frequently elevated in the adipose tissue of obese individuals. Therefore, inhibiting NNMT with 5-Amino-1MQ may represent a novel approach to weight loss intervention.
Metabolic Regulation
5-Amino-1MQ has been associated with beneficial metabolic changes, including improved insulin sensitivity and altered lipid metabolism. This is supported by metabolomic profiling studies that have identified complex lipid species and amino acid analogues associated with the response to weight loss interventions.
NNMT Inhibition and Microbiome Alteration
Research indicates that NNMT inhibition can establish a distinct microbiome profile. This is significant as the gut microbiota has been implicated in the pathogenesis of metabolic diseases. A study on diet-induced obese (DIO) mice demonstrated that a reduced-calorie diet combined with NNMT inhibition resulted in a unique microbiome composition, suggesting potential applications for 5-Amino-1MQ in gut microbiota-related metabolic research.
Enhanced Metabolic Understanding
Research using 5-amino-1MQ can provide deeper insights into the metabolic pathways involved in obesity and related conditions. This can aid in developing targeted therapies and personalised medicine approaches for metabolic disorders.
Legal and Safety Notice:
 
Peptagenix only offers 5-Amino-1MQ solely for research and scientific applications. In support of the research community, we ensure our products comply with all quality and legal standards. Please be advised that 5-Amino-1MQ and other peptides we provide are not intended for human use, diagnostic, or therapeutic purposes.
 
For premium-quality 5-Amino-1MQ for your UK-based research needs, explore our peptide selection for scientific excellence and integrity.